Details for New Drug Application (NDA): 018869
✉ Email this page to a colleague
The generic ingredient in NIMOTOP is nimodipine. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the nimodipine profile page.
Summary for 018869
Tradename: | NIMOTOP |
Applicant: | Bayer Pharms |
Ingredient: | nimodipine |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018869
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 28, 1988 | TE: | RLD: | Yes |
Expired US Patents for NDA 018869
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bayer Pharms | NIMOTOP | nimodipine | CAPSULE;ORAL | 018869-001 | Dec 28, 1988 | ⤷ Sign Up | ⤷ Sign Up |
Bayer Pharms | NIMOTOP | nimodipine | CAPSULE;ORAL | 018869-001 | Dec 28, 1988 | ⤷ Sign Up | ⤷ Sign Up |
Bayer Pharms | NIMOTOP | nimodipine | CAPSULE;ORAL | 018869-001 | Dec 28, 1988 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription